What is the recommended management of hypervitaminosis D–induced hypercalcemia in pediatric patients?

Management of Hypervitaminosis D-Induced Hypercalcemia in Pediatrics

Immediately discontinue all vitamin D supplementation and initiate aggressive intravenous hydration with normal saline, followed by bisphosphonate therapy (pamidronate) as first-line specific treatment for severe hypercalcemia, as this approach demonstrates superior efficacy and lower recurrence rates compared to corticosteroids in pediatric vitamin D intoxication.

Immediate Assessment and Stabilization

When hypervitaminosis D-induced hypercalcemia is suspected, obtain:

• Serum calcium, phosphorus, creatinine, and alkaline phosphatase
• 25-hydroxyvitamin D [25(OH)D] levels (hypervitaminosis D defined as >150 ng/mL) 1
• Parathyroid hormone (PTH) - expect suppressed levels
• Urinary calcium/creatinine ratio
• ECG to assess QTc interval (shortened in hypercalcemia) 2
• Renal ultrasound to evaluate for nephrocalcinosis

Critical point: The development of hypercalcemia is direct evidence of excessive vitamin D dosing 3. Severe hypercalcemia (>15 mg/dL) requires immediate intervention to prevent life-threatening complications including cardiac arrhythmias, acute kidney injury, and neurological deterioration 4, 2.

Severity Stratification

Mild hypercalcemia: Calcium 10.5-12 mg/dL Moderate hypercalcemia: Calcium 12-14 mg/dL
Severe hypercalcemia: Calcium >14 mg/dL 4

Clinical manifestations correlate with severity and include anorexia, vomiting, constipation, weakness, hypotonia, lethargy, polyuria, and in severe cases, altered consciousness 2, 5.

Treatment Algorithm

Step 1: Universal Measures (All Severity Levels)

• Stop all vitamin D supplementation immediately - including multivitamins containing vitamin D 6
• Avoid excessive sun exposure
• Ensure adequate hydration status
• Do NOT restrict dietary calcium without medical supervision 6

Step 2: Hydration Therapy

• Initiate aggressive IV hydration with normal saline (2-3 times maintenance)
• Add loop diuretics (furosemide) ONLY after achieving adequate hydration 4, 2
• Monitor fluid balance, electrolytes, and calcium levels closely

Step 3: Specific Pharmacologic Treatment

For severe hypercalcemia (calcium >14 mg/dL):

Pamidronate is the preferred first-line agent based on comparative effectiveness data showing:

• Significantly lower recurrence rates compared to prednisolone (p=0.02) 4
• More rapid and sustained calcium reduction
• Superior efficacy in pediatric vitamin D intoxication

Dosing: Pamidronate 0.5-1 mg/kg IV infused over 4-6 hours 4, 2

For moderate hypercalcemia or when bisphosphonates are contraindicated:

Corticosteroids (prednisolone) can be used but are less effective - studies show higher rates of treatment failure requiring additional interventions (p<0.001) 4. Mechanism: reduces intestinal calcium absorption and increases vitamin D catabolism.

Critical caveat: Prednisolone should NOT be first-line for severe cases given inferior outcomes 4.

Step 4: Refractory Cases

For hypercalcemia unresponsive to standard therapy:

• Denosumab 60 mg subcutaneously has shown rapid efficacy (calcium reduction within 7 days) in cases with concurrent acute kidney injury where bisphosphonates are relatively contraindicated 7
• Consider hemodialysis for life-threatening hypercalcemia with neurological deterioration or severe cardiac manifestations 2

Special Considerations

Infants and Young Children

• Avoid single large doses >300,000 IU - associated with high risk of hypercalcemia 1
• Infants are particularly vulnerable to severe complications including nephrogenic diabetes insipidus 5
• Williams syndrome patients require extra caution with vitamin D - they have baseline abnormalities in calcium metabolism and increased intestinal calcium absorption 6

Monitoring During Treatment

• Serum calcium every 6-12 hours initially until stable decline
• Daily creatinine and electrolytes
• ECG monitoring for severe cases
• Repeat renal ultrasound to assess for nephrocalcinosis development

Long-term Sequelae

• Nephrocalcinosis is common (30-70% in some series) and may persist despite calcium normalization 8
• Renal function typically recovers but requires long-term monitoring 2, 7
• Neurological recovery is generally complete within 3 months if treated promptly 2
• Venous thrombosis risk from central lines in severe cases requiring dialysis 2

Prevention of Recurrence

The half-life of 25(OH)D is approximately 2-3 weeks, but stored vitamin D can cause prolonged hypercalcemia for months. After acute management:

• Monitor calcium levels weekly until normalized, then monthly for 3-6 months
• Avoid vitamin D supplementation until 25(OH)D levels normalize (<100 ng/mL)
• When restarting (if indicated), use age-appropriate dosing: 400-600 IU/day for infants, 600-1000 IU/day for children 1
• Parent education is critical - many cases result from well-intentioned overdosing due to fear of rickets, particularly in immigrant families 2

Common Pitfalls to Avoid

1. Do not use loop diuretics before adequate hydration - worsens dehydration and kidney injury
2. Do not choose prednisolone as first-line for severe hypercalcemia - inferior efficacy 4
3. Do not restrict dietary calcium - unnecessary and potentially harmful 6
4. Do not use calcitriol, alfacalcidol, or other active vitamin D analogs to treat 25(OH)D-related toxicity 3
5. Do not discharge until calcium trending downward - recurrence rates are significant without appropriate initial treatment

The key to successful management is early recognition, immediate cessation of vitamin D, aggressive hydration, and timely bisphosphonate therapy for severe cases, with careful attention to preventing and monitoring for nephrocalcinosis.